Durability after discontinuation of nucleos(t)ide therapy in chronic HBeAg negative hepatitis patients

BACKGROUND/AIMS: Relapse has been reported after stopping nucleos(t)ide (NUC) therapy in the majority of chronic HBeAg negative hepatitis patients. However, the ideal treatment duration of HBeAg negative chronic hepatitis B (CHB) is not well known. We investigated the frequency of relapse in HBeAg n...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young Jip, Kim, Kichan, Hwang, Sun Hyuk, Kim, Soon Sun, Lee, Dami, Cheong, Jae Youn, Cho, Sung Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796680/
https://www.ncbi.nlm.nih.gov/pubmed/24133668
http://dx.doi.org/10.3350/cmh.2013.19.3.300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796680/
https://www.ncbi.nlm.nih.gov/pubmed/24133668
http://dx.doi.org/10.3350/cmh.2013.19.3.300

Ejemplares similares